James P. Boylan

Insider Reports History

Location
Menlo Park, CA
Signature
/s/ Neil Lerner, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James P. Boylan:

Form 4 holding Director

Immunome Inc.

Security class
Director Stock Option (right to buy)
Shares / value
18,864
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Zenas BioPharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
18,500
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Immunome Inc.

Security class
Stock option (right to buy)
Shares / value
11,333
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by James P. Boylan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .